Navigation Links
Rcadia Medical Imaging Awarded Four U.S. Patents Covering Technology for Automated Analysis of Coronary CT Angiography
Date:6/28/2011

NEWTON, Mass., June 28, 2011 /PRNewswire/ -- Rcadia Medical Imaging today announced that the company has been granted four patents by the U.S. Patent and Trademark Office covering technology for its COR Analyzer® System.  The COR Analyzer performs fully automatic analysis of Coronary CT Angiography (cCTA) studies to accelerate emergency department triage of suspected coronary artery disease (CAD) patients and optimize cardiology and radiology department workflow. The System is marketed in the U.S. and distributed through an agreement with Siemens Healthcare.

"The COR Analyzer is a powerful decision support tool which has shown great potential in clinical trials and routine use to reduce unnecessary admissions and shorten time to treatment," said Shai Levanon, President and CEO of Rcadia. "The patents strengthen the intellectual property position around this innovative system."  He noted that the COR Analyzer is the first of a new category of software applications to broadly enable the use of advanced imaging technologies in emergency medicine to improve care and reduce costs.

The four patents broadly cover methods and algorithms for automated analysis of coronary CT angiography studies and detection of pathologies in coronary arteries. The patents also cover methods for results visualization and automatic assessment of study quality. In addition, the methods are extended to cover the automatic interpretation of triple rule out studies.

Triage of suspected CAD patients represents a major clinical and healthcare economic challenge in the U.S.  An estimated six million patients enter the ED in the U.S. each year with chest pain. Because current diagnostic techniques are often equivocal, an estimated two million, primarily low risk patients, are admitted to the hospital for further testing at an annual cost of $10-$13 billion. In an estimated 85 percent of these patients, an acute coronary event is subsequently ruled out.

About Rcadia Medical Imaging

Rcadia Medical Imaging develops and markets automated image processing software products for blood vessel analysis in patients with suspected cardiovascular disease. The company's first FDA-cleared product, the COR Analyzer® System, provides fully automated, real-time analysis of Coronary CT Angiography to enable the practical application of cCTA in detecting significant coronary artery disease. The COR Analyzer improves the utility of Coronary CTA studies in the emergency department to triage chest pain patients and optimizes work flow in cardiology and radiology departments. Learn more at www.rcadia.com.


'/>"/>
SOURCE Rcadia Medical Imaging Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Rcadias COR Analyzer Family of Products Receives Second FDA Clearance
2. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
3. Rcadia Medical Imaging Wins 2009 AuntMinnie.com Best New Radiology Vendor Award
4. Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call
5. Arcadia Resources to Present at Lazard Healthcare Conference in New York
6. Arcadia Resources Names Stephen Goldsmith to Board of Directors
7. Rcadia Medical Imaging’s COR Analyzer(R) System Receives CE Mark
8. Marcadia and Lilly Sign Development, License Agreement for Novel Glucagon Program in Severe Hypoglycemia
9. Rcadia Announces Five COR Analyzer® Studies to be Presented at SCCT Annual Scientific Meeting
10. Arcadian Healths Chief Information Officer to Address Role of CIOs from a Healthcare Perspective at the CIO Executive Leadership Roundtable in Santa Monica
11. Arcadia Resources Announces Improved Fiscal 2011 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... - Cardiac Marker Diagnostic ... and Cancer Therapy. - European Point of Care ... - Key Diagnostic Testing Markets. - Molecular ... Genetic Testing. - Molecular Diagnostics in Infectious Disease ... Diagnostic Products World Markets. - Point of Care ...
(Date:2/11/2016)... SAN FRANCISCO , Feb. 11, 2016  Kindred ... focused on saving and improving the lives of pets, ... Technical Section of the New Animal Drug Application (NADA) ... the pivotal field study (KB0120) of Zimeta for the ... by the Company. --> ...
(Date:2/11/2016)... 11, 2016  NOIT™ Research LLC, a private, leading-edge ... Change" campaign to assist needy families in obtaining one ... sold between February 10, 2016 and March 31, 2016, ... family. The NOIT is an auditory stimulus that plays ... language skills. Beth Shier , NOIT ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... 2016 , ... Christie Medical Holdings, Inc. presented the Baylor ... Vision vein finder for the nursing school simulation lab. This donation ... blood, combining technology with traditional technique. , “VeinViewer is a wonderful new addition ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mystic Buddha Publishing House presents Valentine’s ... Buddha, the biography of Rama - Dr. Frederick Lenz. , According to ... of a Buddhist teacher for teaching and helping others. Valentine’s Day celebrates love ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... — 1:30 p.m. – 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination ... cycle of pharmaceutical products, garnering increased attention from all stakeholders in the development ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare Center for ... General Hospital on April 5-7. The series is a multi-day, multi-workshop event designed ... workshops cover a broad range of topics, including coaching skills, the scientific method ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... The Jones ... other communities across eastern Texas, is launching a cooperative charity drive with the Tarrant ... , Serving more than 50,000 individuals and families in need, the Tarrant County Food ...
Breaking Medicine News(10 mins):